A major limiting factor is the
cost and complexity of implementing clinical studies,
particularly studies that cross institutions, address
questions relevant to vulnerable populations, or extend
into community care settings. Such studies require
careful screening of participants for eligibility and
clinical appropriateness, as well as intensive monitoring
for compliance with study requirements, accurate
data collection, and documentation of adverse
effects.